Overview
CRISPR and Gene Editing in Hemostasis Disorders , ( ( I ATTACHED to u the criteria for assessment ) ) .
Investigate how CRISPR and other gene-editing technologies are being used to treat bleeding disorders such as hemophilia and von Willebrand disease. Evaluate the practical applications and ethical implications of gene editing in the context of hemostasis.
Key Focus:
- Review current studies using CRISPR to correct genetic mutations in coagulation factors.
- Analyze the risks and challenges associated with gene editing in hemostasis.
- Explore the future possibilities for curing genetic bleeding disorders.
Assignment Objective:
Critically assess whether gene-editing technologies are likely to revolutionize the management of bleeding disorders or if significant challenges remain.